Filing Details
- Accession Number:
- 0001209191-15-049484
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-03 14:49:57
- Reporting Period:
- 2015-06-01
- Filing Date:
- 2015-06-03
- Accepted Time:
- 2015-06-03 14:49:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198230 | J Martha Demski | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-01 | 2,000 | $1.53 | 2,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-01 | 2,000 | $41.58 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-01 | 2,000 | $0.00 | 2,000 | $1.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,126 | 2018-06-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 14,788 | Indirect | By the Martha J. Demski Trust u/a 10/01/94 |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on September 15, 2014.
- The range of sale prices received is $41.38 to $41.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares sold at each separate price.
- Immediately exercisable.
Billionaire Hedge Funds
